NCT07151755 - Microneedle Intra-Arterial Injection for Retinal Artery Occlusion | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2027

Conditions

Central Retinal Artery Occlusion

Interventions

PROCEDURE

Vitrectomy + Direct Intra-Arterial Microneedle Thrombolysis + Standard Care

The patients will receive standard pars plana vitrectomy (PPV) combined with direct intra-arterial microneedle thrombolysis under microscopic visualization, in addition to standard clinical treatment for RAO. A 47G microneedle will be used to deliver thrombolytic agent intra-arterially per protocol.

PROCEDURE

Standard Clinical Care Only

The patients will receive standard clinical treatment for RAO without vitrectomy or intra-arterial microneedle thrombolysis.

Trial Locations (1)

310058

RECRUITING

Eye Center of the Second Affiliated Hospital of Zhejiang University, Hangzhou

All Listed Sponsors

lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER